Exploration into conolidine has triggered discovery of the opioid receptor in the body termed ACKR3/CXCR7. ACKR3 is apparently the most desired target for conolidine, which also disregards the opposite four classical opioid receptors(3). Advances in the comprehension of the cellular and molecular mechanisms of pain as well as the https://erinm874nqr6.wikififfi.com/user